Showing results (141-150 of 315) with videos related to

Sort By:
Pageof 32
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 1997
Use of a food frequency questionnaire to screen for dietary eligibility in a randomized cancer prevention phase III trialC Ritenbaugh, M Aickin, D Taren, et al.
American Journal of Clinical Oncology|October 1, 1990
Phase II study of fludarabine phosphate (NSC 312887) in patients with advanced cervical cancer. A Southwest Oncology Group studyD D Von Hoff, S Green, E A Surwit, et al.
Journal of the National Cancer Institute|August 3, 1988
Predictive model for plasma concentration-versus-time profiles of investigational anticancer drugs in patientsL E Davis, D S Alberts, P M Plezia, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Comparative pharmacokinetics of chlorambucil and melphalan in manD S Alberts, S Y Chang, H S Chen, et al.
Cancer Treatment Reports|July 1, 1985
Methotrexate: bioavailability and pharmacokineticsM A Campbell, D G Perrier, R T Dorr, et al.
Journal of Medicinal Chemistry|August 24, 2000
Analogues of amonafide and azonafide with novel ring systemsS M Sami, R T Dorr, D S Alberts, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Validation of proliferation indices as surrogate endpoint biomarkersD S Alberts, J Einspahr, M Aickin, et al.
Journal of Pharmaceutical Sciences|May 1, 1978
High-pressure liquid chromatographic analysis of melphalan in plasmaS Y Chang, D S Alberts, L R Melnick, et al.
Pageof 32